Abstract
We aimed to compare composite indices with Ultrasound Global Synovitis Score (GLOESS) for remission in rheumatoid arthritis (RA). RA patients in remission according to the clinician were investigated with Disease Activity Score28 (DAS28), Clinical Disease Activity Index (CDAI), Simplified Disease Activity Index (SDAI), and RAPID-3 (Routine Assessment of Patient Index Data 3). Ultrasonography was performed using the GLOESS scores. Patients in CDAI-remission had lower GLOESS (median (IQR), 5(3–9.75) vs 7(4–11.75), p = 0.048) with a similar trend in SDAI (5(3–9.25) vs 7(4–11.25), p = 0.064). This was not observed with DAS28-CRP and RAPID3. Our results show that CDAI is superior to other indices to assess remission in RA.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Smolen JS, Aletaha D, Bijlsma JW et al (2010) Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 69(4):631–637. https://doi.org/10.1136/ard.2009.123919
Gaujoux-Viala C, Mouterde G, Baillet A, Claudepierre P, Fautrel B, Le Loët X, Maillefert JF (2012) Evaluating disease activity in rheumatoid arthritis: which composite index is best? A systematic literature analysis of studies comparing the psychometric properties of the DAS, DAS28, SDAI and CDAI. Joint Bone Spine 79(2):149–155. https://doi.org/10.1016/j.jbspin.2011.04.008
Muñoz JGB, Giraldo RB, Santos AM, Bello-Gualteros JM, Rueda JC, Saldarriaga EL, Angarita JI, Arias-Correal S, Vasquez AY, Londono J (2017) Correlation between rapid-3, DAS28, CDAI and SDAI as a measure of disease activity in a cohort of Colombian patients with rheumatoid arthritis. Clin Rheumatol 36(5):1143–1148. https://doi.org/10.1007/s10067-016-3521-5
Brown AK, Conaghan PG, Karim Z, Quinn MA, Ikeda K, Peterfy CG, Hensor E, Wakefield RJ, O'Connor PJ, Emery P (2008) An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis. Arthritis Rheum 58(10):2958–2967. https://doi.org/10.1002/art.23945
Foltz V, Gandjbakhch F, Etchepare F, Rosenberg C, Tanguy ML, Rozenberg S, Bourgeois P, Fautrel B (2012) Power Doppler ultrasound, but not low-field magnetic resonance imaging, predicts relapse and radiographic disease progression in rheumatoid arthritis patients with low levels of disease activity. Arthritis Rheum 64(1):67–76. https://doi.org/10.1002/art.33312
Balsa A, de Miguel E, Castillo C, Peiteado D, Martín-Mola E (2010) Superiority of SDAI over DAS-28 in assessment of remission in rheumatoid arthritis patients using power Doppler ultrasonography as a gold standard. Rheumatology (Oxford) 49:683–690
D'Agostino MA, Wakefield RJ, Berner-Hammer H, Vittecoq O, Filippou G, Balint P, Möller I, Iagnocco A, Naredo E, Østergaard M, Boers M, Gaillez C, van Holder K, le Bars M, OMERACT-EULAR-Ultrasound Task Force (2016) Value of ultrasonography as a marker of early response to abatacept in patients with rheumatoid arthritis and an inadequate response to methotrexate: results from the APPRAISE study. Ann Rheum Dis 75(10):1763–1769. https://doi.org/10.1136/annrheumdis-2015-207709
van der Linden MP, Knevel R, Huizinga TW, van der Helm-van Mil AH (2011) Classification of rheumatoid arthritis: comparison of the 1987 American College of Rheumatology criteria and the 2010 American College of Rheumatology/European League Against Rheumatism criteria. Arthritis Rheum 63(1):37–42. https://doi.org/10.1002/art.30100
Wakefield RJ, Balint PV, Szkudlarek M et al (2005) Musculoskeletal ultrasound including definitions for ultrasonographic pathology. J Rheumatol 32(12):2485–2487
Haugeberg G, Hansen IJ, Soldal DM, Sokka T (2015) Ten years of change in clinical disease status and treatment in rheumatoid arthritis: results based on standardized monitoring of patients in an ordinary outpatient clinic in southern Norway. Arthritis Res Ther 17(1):219. https://doi.org/10.1186/s13075-015-0716-0
Makinen H, Kautiainen H, Hannonen P, Sokka T (2005) Is DAS28 an appropriate tool to assess remission in rheumatoid arthritis? Ann Rheum Dis 64(10):1410–1413. https://doi.org/10.1136/ard.2005.037333
Balsa A, de Miguel E, Castillo C, Peiteado D, Martin-Mola E (2010) Superiority of SDAI over DAS-28 in assessment of remission in rheumatoid arthritis patients using power Doppler ultrasonography as a gold standard. Rheumatology (Oxford) 49(4):683–690. https://doi.org/10.1093/rheumatology/kep442
Padovano I, Costantino F, Breban M, D'Agostino MA (2016) Prevalence of ultrasound synovial inflammatory findings in healthy subjects. Ann Rheum Dis 75(10):1819–1823. https://doi.org/10.1136/annrheumdis-2015-208103
Dale J, Stirling A, Zhang R, Purves D, Foley J, Sambrook M, Conaghan PG, van der Heijde D, McConnachie A, McInnes IB, Porter D (2016) Targeting ultrasound remission in early rheumatoid arthritis: the results of the TaSER study, a randomised clinical trial. Ann Rheum Dis 75(6):1043–1050. https://doi.org/10.1136/annrheumdis-2015-208941
Haavardsholm EA, Aga AB, Olsen IC et al (2016) Ultrasound in management of rheumatoid arthritis: ARCTIC randomised controlled strategy trial. BMJ 354:4205
Han J, Geng Y, Deng X, Zhang Z et al (2016) Subclinical synovitis assessed by ultrasound predicts flare and progressive bone erosion in rheumatoid arthritis patients with clinical remission: a systematic review and metaanalysis. J Rheumatol 43(11):2010–2018. https://doi.org/10.3899/jrheum.160193
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
SZA received grants and/or honoraria from Abbvie, Novartis, UCB, Sanofi and Pfizer.
Rights and permissions
About this article
Cite this article
Olmez, M.O., Gunal, E.K., Ureyen, S.B. et al. Comparison of composite indices with global synovitis score on ultrasound for detecting remission. Clin Rheumatol 37, 1111–1114 (2018). https://doi.org/10.1007/s10067-017-3925-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-017-3925-x